drugset / Trial / NCT06232005

Intralesional Injection of Mitomycin C Following Visual Internal Urethrotomy for Recurrent Urethral Stricture

NCT06232005

Phase 2/3 Completed 50 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the effectiveness of administering mitomycin C through intralesional injection after performing visual internal urethrotomy (VIU) for the treatment of recurring urethral stricture.

Timeline

Start
2022-01-01
Primary completion
2023-01-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified Other

Indications